ÂÜÀòÂÒÂ×

Benjamin Miller currently serves as the VP, Global Asset Lead for Elafibranor at Ipsen since March 2022. Prior to this role, Benjamin held positions at Morningside BioPharma Advisory, overseeing clinical research as VP and Senior Director from June 2020 to March 2022. During the tenure at Alexion Pharmaceuticals, Inc. from May 2018 to June 2020, Benjamin contributed as Senior Director of Global Medical Affairs. Previous roles include positions in Global Medical Affairs at Shire and as Regional Director of Medical Affairs at Merck. Benjamin's career began at Cubist Pharmaceuticals, where contributions ranged from Senior Clinical Research Scientist to Clinical Research Fellow. Benjamin holds a Doctor of Pharmacy (PharmD) degree from Ohio Northern University, completed in 2010.